A new company integrating advanced laboratory services and clinical trials services announced it will operate under the name med fusion and will be headquartered in Dallas, Texas.

Baylor Health Care System, Texas Oncology PA, Pathologists Biomedical Laboratories LLP and US Oncology have joined to create a new patient-focused support model for medicine. Together, with its clients, med fusion will offer advanced laboratory and clinical trials services which will leverage patient information to enable clinical trials research, reduce the cost of patient treatment and improve personalized care.

med fusion will begin operations this spring; the company plans to hire 320 employees next year and have more than 900 employees by 2014. med fusion has leased 172,000 square feet at the ConVergence Office Center in Lewisville, Texas. “We selected the name med fusion because it describes the convergence of laboratory services, clinical research data and patient care support,” said Keith Laughman, med fusion CEO. “Our coordinated holistic approach facilitates more effective patient care, greater access to information and technology, collaboration for clinicians and optimized allocation of resources for healthcare institutions.”

There are many benefits to integrating these services, including:

• Patient information from clinical trials will be delivered in a more timely manner to support physicians as they determine how best to treat their patients.
   
• Data from clinical trials will also provide insights for and drive adoption of new clinically validated diagnostic tests.
   
• Patient laboratory reports will be more integrated, and will take into consideration patient histories so physicians can make more precise diagnoses and recommend more specific treatments.
   
• The new model will narrow the gap between diagnostic testing and therapeutic development, supporting the process of getting new therapies to market quicker.

About med fusion

med fusion will offer clinical laboratory services for hospitals including full service reference lab services such as pathology testing and molecular diagnostics. The company will also provide pharmaceutical and biotechnology companies with clinical trial services including central laboratory services, contract research organization services and site management services.

Source: med fusion